Supplements that aren’t a magic fix, but you are taking them anyway
The supplement sales have surpassed $150 billion in the United States in 2023. There are over 80,000 unique…
Harnessing “DNA surgery” to develop therapeutic medicines for genetic liver and heart diseases
Genome editing is increasingly recognzed as a leading frontier in biomedical research and an essential driver of healthcare…
Study shows prediabetes remission does not always require weight loss
New evidence shows that restoring normal glucose regulation can shield against diabetes even without weight loss, reshaping prevention…
Categorizing the risk factors for portal vein thrombosis in liver cirrhosis
Portal vein thrombosis (PVT) is a critical complication in liver cirrhosis (LC), significantly worsening portal hypertension and accelerating…
Genetic variant linked to liver injury after chemotherapy in colorectal cancer patients
A new international study led by Mayo Clinic researchers has identified a genetic factor that may explain why some patients…
Precision probiotics lower blood sugar and cholesterol in mice
A new mouse study reveals that carefully selected probiotics can lower blood sugar, body fat, and cholesterol levels…
Study identifies key molecular and clinical biomarkers for MASLD
Background and aims The causal biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD) and their clinical value remain…
Intravenous lactate raises pro-BDNF levels similar to high intensity workouts
Science has confirmed what sports lovers have always known from experience: exercise is good for the brain. It…
Magnetically-powered nanorobots enhance drug uptake in tumors
Spiky nanorobots powered by magnets have been developed to carry drugs and pierce tumor cell membranes, a key…
Coffee protects the liver by blocking inflammation and scarring, review finds
Scientists reveal how your daily cup of coffee may guard against liver disease, connecting population trends with the…
Three Health Conditions Raise Death Risk For Fatty Liver Disease | Health
Key Takeaways Three conditions increase risk of death for people with fatty liver disease High blood pressure, diabetes…
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…